Joseph Keegan

Joseph Keegan

Directeur/Membre du Conseil chez INTERPACE BIOSCIENCES, INC.

Fortune : 799 427 $ au 31/05/2026

73 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Joseph D.
Keegan
is Executive Chairman at Carterra, Inc. since 2015, Chairman at Labcyte, Inc. since 2012, Chairman at Arrayjet Ltd. since 2017, Executive Chairman at Optofluidics, Inc. since 2018, Chairman at Fluidic Analytics Ltd. since 2019, Independent Director at Bio-Techne Corp.
since 2017, Independent Director at Interpace Biosciences, Inc. since 2016, Independent Director at Biolog, Inc., Director at San Francisco Opera Association, Director at Advanced Cell Diagnostics, Inc. since 2013, Independent Director at Nuclera Ltd., and President at Universal Imaging Corp.
Former roles include Chief Executive Officer at Molecular Devices LLC from 1998 to 2007, Chief Executive Officer at Aria Biosystems Corp.
from 2007 to 2012, Chief Executive Officer at Pall ForteBio LLC, Chief Executive Officer at Molecular Devices Corporation from 1998 to 2007, Chairman at Seahorse Bioscience, Inc. in 2011, Director at Response Biomedical Corp., Director at Stereotaxis, Inc. from 2013 to 2016, Director at BioImagene, Inc., Director at Courtagen Life Sciences, Inc., Director at Cardea Bio, Inc. from 2016 to 2018, Independent Director at ProteinSimple in 2014, Director at Alpha Innotech Corp.
from 2007 to 2009, Director at Essen BioScience, Inc., Director at Upstate USA, Inc., Director at Unchained Labs LLC, Director at Analytical Life Science & Diagnostics Association, President-Worldwide Tissue Culture at Becton, Dickinson & Co. from 1992 to 1998, Lead Engineer at GE Aerospace, Lead Engineer at HP, Inc., and Vice President at Leica Geosystems, Inc. from 1988 to 2011.
Education includes a doctorate from Stanford University and an undergraduate degree from Boston University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/10/2025 15 411 ( 0,01 % ) 796 440 $ 31/05/2026
15/04/2026 1 757 ( 0,01 % ) 2 987 $ 31/05/2026

Postes actifs de Joseph Keegan

SociétésPosteDébut
INTERPACE BIOSCIENCES, INC. Directeur/Membre du Conseil 01/01/2016
BIO-TECHNE CORPORATION Directeur/Membre du Conseil 26/10/2017
Directeur/Membre du Conseil 09/12/2013
Président 01/01/2015
Président 20/12/2018
Président -
Président 26/09/2019
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ -

Anciens postes connus de Joseph Keegan

SociétésPosteFin
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Joseph Keegan

Formation de Joseph Keegan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

55

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Health Technology

Electronic Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Health Technology

Electronic Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Durables

Producer Manufacturing

Health Technology

Industrial Services

Health Technology

Upstate USA, Inc.

Health Technology

Health Technology

Analytical Life Science & Diagnostics Association

Health Technology

Health Technology

Health Technology

Molecular Devices Corporation

  1. Bourse
  2. Insiders
  3. Joseph Keegan
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇